Ingrid Berenice Montoya-Delgado

Dr. Ingrid Berenice Montoya-Delgado

Fisiología, Universidad de Guadalajara, Jalisco, Mexico
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MAMariana Araiza-Guzmán
Mariana Araiza-Guzmán
BZBricia Melissa Gutierrez Zepeda
Bricia Melissa Gutierrez Zepeda
ASAna M. Saldaña-Cruz
Ana M. Saldaña-Cruz
Ingrid Berenice Montoya-DelgadoIngrid Berenice Montoya-Delgado
Ingrid Berenice Montoya-Delgado
DDDiana Alejandra Rubio Delgado
Diana Alejandra Rubio Delgado
BCBetsabe Contreras-Haro
Betsabe Contreras-Haro
Background: Mutations in the TP53 gene can alter its tumor suppressor functions, thereby promoting oncogenic activity. The TP53 IVS3 16 bp genetic variant overlaps with nucleotide sequences that can alter regulatory structures, potentially affecting its function. The aim of the present study was to evaluate the association between TP53 IVS3 16 bp genetic variant and the risk of breast cancer (BC) in women from western Mexico. Methods: The study included 220 women diagnosed with BC and 198 cancer-free controls. Clinical and demographic data were collected through structured questionnaires and verified with medical records. Genotyping of the TP53 IVS3 16 bp genetic variant was performed using polymerase chain reaction (PCR) and visualized on 6% polyacrylamide gels. Results: Compared to controls, women with BC more frequently reported a family history of the disease and menopausal status (p < 0.05). Genotypic analysis revealed that carriers of the D/I genotype and the combined D/I + I/I genotypes were associated with a reduced risk of BC in codominant (OR = 0.53; 95% CI 0.32–0.88) and dominant (OR = 0.57; 95% CI 0.35–0.93) models. Conclusions: The D/I and D/I + I/I genotypes in codominant and dominant models showed a lower risk against BC. More studies are needed to confirm these findings.

30 September 2025
Verified
Journal Article
Closed access
Ingrid Berenice Montoya-DelgadoIngrid Berenice Montoya-Delgado
Ingrid Berenice Montoya-Delgado
BGBricia Melissa Gutierrez-Zepeda
Bricia Melissa Gutierrez-Zepeda
AQAntonio Quintero-Ramos
Antonio Quintero-Ramos
IOItzel Vianey Ochoa-García
Itzel Vianey Ochoa-García
MOMargarita Ortega-Cisneros
Margarita Ortega-Cisneros
ADAdrian Daneri-Navarro
Adrian Daneri-Navarro

Verified
Journal Article
Open access
PDF file
Ingrid Berenice Montoya-DelgadoIngrid Berenice Montoya-Delgado
Ingrid Berenice Montoya-Delgado
IOItzel Vianey Ochoa-García
Itzel Vianey Ochoa-García
ZSZaira Escobedo Salcedo
Zaira Escobedo Salcedo
MOMargarita Ortega-Cisneros
Margarita Ortega-Cisneros
ATAlicia Del Toro-Arreola
Alicia Del Toro-Arreola
Antonio Quintero RamosAntonio Quintero Ramos
Antonio Quintero Ramos
Severe asthma (SA) is a chronic respiratory disease characterized by clinical heterogeneity and poor therapeutic response. Variants in the IL4 gene, including rs2243250 and rs2243248, have been associated with asthma susceptibility and severity in different populations; however, their role in the Mexican population remains unclear. This study evaluated the association of IL4 promoter variants rs2243250 and rs2243248 with SA and related clinical characteristics in a Mexican population using genetic and in silico approaches. In total, 106 patients with SA and 180 healthy individuals were included. Genotyping was performed using allelic discrimination assays with TaqMan® probes, and associations between genotypes and clinical variables were assessed. No significant differences in allele or genotype frequencies were observed between groups. However, the rs2243250 TT genotype was associated with nocturnal symptoms (OR = 3.03, 95% CI = 1.31–7.00, p = 0.009) and increased use of rescue medication (OR = 3.16, 95% CI = 1.41–7.07, p = 0.005). The rs2243248 TG/GG genotypes were associated with epithelial allergy (p < 0.05). In silico analysis suggested a regulatory role for both variants. These findings suggest that IL4 variants may not influence overall disease risk but could modulate clinical features of asthma severity.

8 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Ingrid Berenice Montoya-DelgadoIngrid Berenice Montoya-Delgado
Ingrid Berenice Montoya-Delgado
IOItzel Vianey Ochoa-García
Itzel Vianey Ochoa-García
ZSZaira Escobedo Salcedo
Zaira Escobedo Salcedo
MOMargarita Ortega-Cisneros
Margarita Ortega-Cisneros
ATAlicia Del Toro-Arreola
Alicia Del Toro-Arreola
Antonio Quintero RamosAntonio Quintero Ramos
Antonio Quintero Ramos
Severe asthma (SA) is a chronic respiratory disease characterized by clinical heterogeneity and poor therapeutic response. Variants in the IL4 gene, including rs2243250 and rs2243248, have been associated with asthma susceptibility and severity in different populations; however, their role in the Mexican population remains unclear. This study evaluated the association of IL4 promoter variants rs2243250 and rs2243248 with severe asthma and its clinical characteristics in a Mexican population using genetic and in silico approaches. A total of 106 patients with SA and 180 healthy individuals were included. Genotyping was performed using allelic discrimination assays with TaqMan® probes, and associations between genotypes and clinical variables were assessed. No significant differences in allele or genotype frequencies were observed between groups. However, the rs2243250 TT genotype was associated with nocturnal symptoms (OR = 3.03, 95% CI = 1.31–7.00, p = 0.009) and increased use of rescue medication (OR = 3.16, 95% CI = 1.41–7.07, p = 0.005). The rs2243248 TG/GG genotypes were associated with epithelial allergy (p < 0.05). In silico analysis suggested a regulatory role for both variants. These findings suggest that IL4 variants may not influence overall disease risk but could modulate clinical features of asthma severity.